Research graph
References from The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2004 · External reference
Radioactive yttrium 90: A review of its properties, biological behavior, and clinical uses
10.3109/02841866409134063 · 1964 · External reference
Emission of β+ particles via internal pair production in the 0+ – 0+ transition of 90Zr: Historical background and current applications in nuclear medicine imaging
10.3390/atoms1010002 · 2013 · External reference
Scanning bremsstrahlung of yttrium-90 microspheres injected intra-arterially
10.1148/88.4.719 · 1967 · External reference
Studies on the blood supply of tumors in man. III. Vascular patterns of the liver by hepatic arteriography in vivo
1951 · External reference
The blood supply of neoplasms in the liver
1954 · External reference
Unresolved reference
2016 · External reference
Intra-arterial radioisotopes to treat cancer
1960 · External reference
Intra-arterial irradiation of carcinoid tumors of the liver
10.2214/ajr.102.3.552 · 1968 · External reference
The treatment of cancer metastases in the lung by means of radiating microspheres
1966 · External reference
Preoperative irradiation of osteogenic sarcoma with intra-arterially injected yttrium-90 microsphers
10.1002/1097-0142(196803)21:3<453::aid-cncr2820210315>3.0.co;2-w · 1968 · External reference
The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth
1974 · External reference
The blood supply of colorectal liver metastases
10.1038/bjc.1978.283 · 1979 · External reference
Internal radiation therapy of hepatic cancer
10.1007/bf02586901 · 1979 · External reference
Internal radiotherapy for hepatic metastases II: The blood supply to hepatic metastases
10.1016/0022-4804(83)90018-5 · 1983 · External reference
Distribution of different sized microspheres in experimental hepatic tumours
10.1016/0277-5379(87)90416-0 · 1987 · External reference
Intraarterial yttrium 90 in the treatment of hepatic malignancy
10.1148/radiology.142.3.7063703 · 1982 · External reference
Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres
2015 · External reference
90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging
10.1097/01.rvi.0000179815.44868.66 · 2005 · External reference
Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience
2011 · External reference
Outcomes of Therasphere radioembolization for colorectal metastases
2015 · External reference
Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intraarterial administration of chemotherapy and radioactive isotopes
10.1002/jso.2930200304 · 1982 · External reference
Treatment of liver tumours with yttrium-90 microspheres
1983 · External reference
Therapy with Intraarterial microspheres
1987 · External reference
Selective internal radiation therapy: distribution of radiation in the liver
10.1016/0277-5379(89)90109-0 · 1989 · External reference
Effects of hepatic arterial yttrium 90 glass microspheres in dogs
10.1002/1097-0142(19880401)61:7<1336::aid-cncr2820610711>3.0.co;2-k · 1988 · External reference
Hepatic malignancies: Improved treatment with intraarterial Y-90
10.1148/radiology.169.2.3174978 · 1988 · External reference
Regional delivery of microspheres to liver metastases: The effects of particle size and concentration on intrahepatic distribution
10.1038/bjc.1991.459 · 1991 · External reference
Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rate
10.1002/jso.2930420313 · 1989 · External reference
Regression of liver metastases following treatment with yttrium-90 microspheres
10.1111/j.1445-2197.1992.tb00006.x · 1992 · External reference
Treatment of colorectal liver metastases with SIR-Spheres plus chemotherapy
2000 · External reference
Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer
10.1023/a:1013569329846 · 2001 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Hepatocellular carcinoma: Pilot trial of treatment with Y-90 microspheres
10.1148/radiology.172.3.2549567 · 1989 · External reference
Hepatic radioembolization with yttrium-90 containing glass microspheres: Preliminary results and clinical follow-up
1994 · External reference
Unresolved reference
External reference
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres
2000 · External reference
Unresolved reference
External reference
Unresolved reference
2014 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Vascularization of small liver metastases
10.1002/bjs.1800760607 · 1989 · External reference
Advances in radioembolization - Embolics and isotopes
2011 · External reference
Specific gravity of blood and plasma at 4 and 37 degrees C
10.1093/clinchem/20.5.615 · 1974 · External reference
Unresolved reference
2015 · External reference
Unresolved reference
2012 · External reference
Therapeutic use of 90Y microspheres
10.1016/0883-2897(87)90047-x · 1987 · External reference
Unresolved reference
External reference
Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort
10.1007/s00259-013-2575-8 · 2014 · External reference
Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments
10.1007/s00270-008-9348-y · 2008 · External reference
Selective internal radiation therapy: Quantifying distal penetration and distribution of resin and glass microspheres in a surrogate arterial model
10.1016/j.jvir.2015.02.022 · 2015 · External reference
Computational fluid dynamics modeling of 90Y microspheres in human hepatic tumors
10.4172/2155-9619.1000112 · 2011 · External reference
Early arterial stasis during resin-based yttrium-90 radioembolization: Incidence and preliminary outcomes
10.1111/hpb.12135 · 2014 · External reference
Treatment parameters and outcome in 680 treatments of internal radiation with resin 90Y-microspheres for unresectable hepatic tumors
10.1016/j.ijrobp.2008.10.005 · 2009 · External reference
Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: Histological findings
10.1007/s00270-009-9592-9 · 2009 · External reference
Hemolysis due to intravenous injection of distilled water
10.1001/jama.1914.02560380016005 · 1914 · External reference
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease
10.1001/jama.293.13.1653 · 2005 · External reference
Hemoglobin research and the origins of molecular medicine
10.1182/blood-2008-04-078188 · 2008 · External reference
Unresolved reference
External reference
Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration
10.1186/s13550-015-0133-z · 2015 · External reference
Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): Assessment of hepatic arterial embolization
10.1007/s00270-005-0171-4 · 2006 · External reference
Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations
2006 · External reference
Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium
10.1016/j.ijrobp.2006.11.060 · 2007 · External reference
Body surface area and body weight predict total liver volume in Western adults
10.1053/jlts.2002.31654 · 2002 · External reference
Unresolved reference
External reference
Liver disease induced by radioembolization of liver tumors: Description and possible risk factors
10.1002/cncr.23339 · 2008 · External reference
Unresolved reference
External reference
Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations
10.1097/01.rvi.0000233785.75257.9a · 2006 · External reference
Radioembolization for neuroendocrine liver metastases: Safety, imaging, and long-term outcomes
10.1016/j.ijrobp.2011.07.041 · 2012 · External reference
Standards of practice in transarterial radioembolization
10.1007/s00270-013-0600-8 · 2013 · External reference
Unresolved reference
2014 · External reference
10.1016/j.jvir.2013.10.056
10.1016/j.jvir.2013.10.056 · 2014 · External reference
Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: A preliminary assessment of this novel treatment option
10.1245/s10434-009-0777-x · 2010 · External reference
Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): Guidelines from the NET-Liver-Metastases Consensus Conference
10.1111/hpb.12326 · 2015 · External reference
Safety, efficacy, and prognostic factors after radioembolization of hepatic metastases from breast cancer: A large single-center experience in 81 patients
10.2967/jnumed.115.165050 · 2016 · External reference
90Y radioembolization of metastatic breast cancer to the liver: Toxicity, imaging response, survival
10.1016/j.jvir.2007.02.019 · 2007 · External reference
Selective internal yttrium-90 radioembolization therapy (90Y-SIRT) versus best supportive care in patients with unresectable metastatic melanoma to the liver refractory to systemic therapy: Safety and efficacy cohort study
2014 · External reference
Hepatic yttrium-90 radioembolization for metastatic melanoma: A single-center experience
10.1097/cmr.0000000000000051 · 2014 · External reference
Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver
10.1016/j.jvir.2011.11.007 · 2012 · External reference
Yttrium-90-labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies
10.1016/j.jvir.2007.11.002 · 2008 · External reference
Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma
10.1186/s12885-015-1822-8 · 2015 · External reference
Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer
10.1002/jso.20141 · 2004 · External reference
Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy
10.1200/jco.2006.08.7916 · 2007 · External reference
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer
10.1200/jco.2015.66.1181 · 2016 · External reference
10.1186/1471-2407-14-497
10.1186/1471-2407-14-497 · 2014 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
Unresolved reference
External reference
